Publications

Peer Reviewed Journal Publications

Oderda G, Asche C, Jones K, Merrill R, Spalding J, "Characterization of therapy and costs for patients with uterine fibroids in Utah medicaid"  Archives of Gynecology and Obstetrics , 2007, Mar 7; [Epub ahead of print]
 
Brooks T, Creekmore F, Young D, Asche C, Oberg B, Samuelson W, "Hospitalization and emergency room visit rates in asthma and chronic pulmonary disease patients taking beta-blockers" Pharmacotherapy (accepted, 2006)
 
Asche CV, Seal B, Jackson K, Odera G, "Economic evaluations in pain management: Principles and methods" Journal of Pain and Palliative Care Pharmacotherapy, 2006, September, 20 (3).
 
Sbarbaro J, Nicolau D, Asche C, "Management of community-acquired respiratory tract infections in an era of increasing antibiotic resistance" Pharmacy and Therapeutics, 2006, February, 31 (5) 106-111.
 
Halpern MT, Schmier JK, Snyder LM, Asche C, Sarocco P, Nieman R, Lavin B, Mandell L  "Meta-analysis of anti-microbial failure"  Journal of Antimicrobial Chemotherapy, 2005, May; 55(5)748-757.
 
Tellier G, Chang JR, Asche CV, Lavin B Stewart J, Sullivan SD "Healthcare resource utilization associated with telithromycin for 5 or 7 days and clarithromycin for 10 days in the treatment of community-acquired pneumonia"  Current Medical Research and Opinion, 2004, 20 (5) 739-747.

Niederman MS, Chang JR, Stewart J, Asche CV, Lavin B, Nusrat R, Sullivan SD  "Hospitalization rates among patients with community-acquired pneumonia treated with telithromycin vs. clarithromycin results from two randomized, double-blind, clinical trials"  Current Research and Medical Opinion, 2004, 20 (7) 969-980.

Colice GL, Morley MA, Asche C, Birnbaum HG "Economic impact of antibiotic resistance in the treatment of community acquired pneumonia" Chest, 2004, Jun; 125(6) 2140-5.

Maroun J, Asche C, Romeyer F, Mukherjee J, Cripps C, Oza A, Skillings J, Letarte J  "A cost comparison of oral tegafur plus uracil/folinic acid and parenteral fluorouracil for colorectal cancer in Canada" Pharmacoeconomics, 2003; 21(14) 1039-51.

Reinharz D, Saldana VR, Follador W, Asche C  "Pharmacoeconomic component of a clinical trial conducted in Latin America"  Conceptual and empirical considerations  Int J Technol Assess Health Care, 2001, Fall; 17(4) 571-8.

Coyte PC, Croxford R, Asche CV, To T, Feldman W, Friedberg J, "Physician and Population Determinants of Rates of Middle Ear Surgery in Ontario, Canada" Journal of the American Medical Association, 28617, 2128-2135, 2001.
 
McIsaac WJ, Coyte PC, Croxford R, Asche CV, Friedberg J, Feldman W  "Otolaryngologists' perceptions of the indications for tympanostomy tube insertion in children" Canadian Medical Association Journal, 2000, May 2; 162(9) 1285-8.

Coyte PC, Asche CV, Elden LM, "The Economic Cost of Otitis Media in Canada" International Journal of Pediatric OtoRhinoLaryngology, 4927-36, 1999.
 
Coyte PC, Asche CV, Croxford R, Chan B, "The Economic Cost of Musculoskeletal Disorders in Canada" Arthritis Care and Research, 115, October, 315-325, 1998.
 
Coyte PC, Asche CV, Brassard T, Ho E, Friedberg J, "Comparative Cost Analysis of Myringotomy with Insertion of Ventilation Tubes in Ontario and British Columbia" Journal of Otolaryngology, 272, 69-75, 1998.
 
Asche CV, Ho E, Chan B, Coyte PC, "Economic Consequences of Multiple Sclerosis for Canadians" Acta Neurologica Scandinavica, 955, 268-274, 1997.

Letters

Halpern MT, Schmier JK, Asche C, Sarocco PW, Mandell LA "Meta-analysis of bacterial resistance to macrolides - providing generalizable results authors' response" J Antimicrob Chemother, 2005, Aug; 56 (2): 433-5.

Asche CV, Oderda G, Brixner D "Has the cost-effectiveness of Xolair® (omalizumab) been underestimated?"  The Journal of Allergy & Clinical Immunology, 2005 May; 115(5) 1095.

Asche CV "Explicit mention of outcomes in prescribing information" Journal of Pain & Palliative Care Pharmacotherapy, 2005 19 (2) 45-47.

Niederman MS, Asche C, Chang JR, Lavin B, Nieman RB, Nusrat R, Stewart J "Letter to the Editor Response to Comment Concerning Niederman MS et al" Current Medical Research & Opinion, 2004; 20(5) 749-758.

Asche C, Meister F, Stewart J, Nieman R, Chang JR. Comparison of healthcare utilization in patients with acute exacerbations of chronic bronchitis receiving telithromycin versus clarithromycin in a randomized, double blind, multicenter clinical trial. Western Society of Allergy, Asthma and Immunology (WSAAI) Annual Meeting, Hawaii, 2004

Asche C, Meister F, Stewart J, Cadihac M, Nieman RB, Chang JR. Telithromycin results in fewer hospitalizations than amoxicillin-clavulanate in the outpatient treatment of acute exacerbations of chronic bronchitis. Western Society of Allergy, Asthma and Immunology (WSAAI) Annual Meeting, Hawaii, 2004

Asche C, Singer ME. Effectiveness of telithromycin vs. azithromycin in the outpatient treatment of community-acquired pneumonia. Academy of Managed Care Pharmacy's (AMCP) 16th Annual Meeting & Showcase Program, San Francisco, 2004

Singer ME, Jaffe DH, Coyte PC, Asche CV. Acute sinusitis in managed care: Antibiotic treatment and outcomes. International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Meeting, Arlington, 2004

Thompson D, Amorosi SL, Taylor DCA, Stokes M, Asche CV, Hadley JA, Ferguson BJ. The cost of treatment failure in acute bacterial maxillary sinusitis. International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Meeting, Arlington, 2004

Halpern MT, Schmier JK, Snyder LM, Asche C, Mandell L. Meta-Analysis of bacterial resistance to macrolides. American Thoracic Society (ATS) Meeting, Orlando, 2004

Asche CV, Coyte PC. The effect of patient socio-economic status on small area variation in ventilation tube Insertion rates in Ontario. Canadian Association for Health Services and Policy Research (CAHSPP) Conference, Montreal, 2004

Thompson D, Ferguson B, Hadley J, Amorosi S, Taylor D, Stokes M, Asche C, Patel M, Lavin B. The impact of acute bacterial sinusitis on health-related quality of life and medical-care costs. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)Annual Meeting, Washington, 2004

Taylor DCA, Torrance G, Norman G, Thompson D, Amorosi SL, Asche C, Ferguson BJ. Validation of a 5-item sinusitis symptom survey for use as a tool in the treatment of acute maxillary sinusitis. International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Meeting, Hamburg, 2004

Brixner D, Asche C, Chang J, Stewart J, Paladino JA. Economic value of telithromycin vs. clarithromycin in the treatment of community-acquired pneumonia. American Society of Health-System Pharmacists (ASHP) Meeting, Orlando, 2004

Singer M, Asche C. Acute bacterial rhinosinusitis in managed care: Treatment and outcomes. American Society of Health-System Pharmacists (ASHP) Meeting, Orlando, 2004

Singer M, Asche C. Mild acute rhinosinusitis: Cost-effectiveness of telithromycin vs. azithromycin. The American College of Allergy, Asthma & Immunology (ACAAI) Meeting, Boston, 2004

Singer ME, Asche C. Acute bacterial rhinosinusitis: a decision analysis of antibiotic strategies. Academy of Managed Care Pharmacy (AMCP) Seventh Annual Meeting, Tampa, 2003

Singer ME, Asche C. Effectiveness of telithromycin versus azithromycin in the outpatient treatment of community-acquired pneumonia. American Thoracic Society (ATS) Meeting, Seattle, 2003

Sullivan SD, Asche C, Lavin B, Patel M, Koro C, Stewart J, Chang J. Cost comparison of telithromycin for 5 or 7 days compared to clarithromycin for 10 days for the treatment of community-acquired pneumonia. American Thoracic Society (ATS) Meeting, Seattle, 2003

Chang JR, Stewart J, Asche C, Nieman RB. Telithromycin is associated with lower overall Healthcare costs than clarithromycin in the treatment of community-acquired pneumonia. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) Annual Meeting, Glasgow, 2003

Chang JR, Stewart J, Asche C, Nieman RB, Davey PG. Lower overall health costs with Telithromycin versus clarithromycin in community-acquired pneumonia. European Respiratory Society (ERS) Annual Meeting, Vienna, 2003

Singer ME, Harding I, Asche C, Jaffe DH. Impact of antibiotic resistance on cost and effectiveness in the treatment of pneumococcal pneumonia. Infectious Diseases Society of America (IDSA) Annual Meeting, Chicago, 2002
Singer ME, Harding I, Asche C, Jaffe DH. Potential impact of rising quinolone resistance in community-acquired pneumonia. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual Meeting, Chicago, 2002

Singer ME, Harding I, Asche C, Jaffe DH. Regional variation in resistant streptococcus pneumoniae: impact on outcomes in community acquired pneumonia. American College of Chest Physicians (ACCP) -Chest Annual Meeting, San Diego, 2002

Asche C, Maroun JA, Romeyer F, Mukherjee J, Cripps C, Oza A, Skillings JR, Letarte J. A pharmacoeconomic comparison of oral uracil/leucovorin to parenteral 5-fluorouracil /leucovorin for colorectal cancer in Canada. 11th Annual Bristol-Myers Squibb Wallingford Scientific Symposium, Bristol-Myers Squibb Pharmaceutical Research Institute, 2000

Chang JR, Stewart J, Asche C, Nieman RB. Telithromycin is associated with lower overall healthcare costs than clarithromycin in the treatment of community-acquired pneumonia. Value in Health, 2000; 6(3): 258

Colice GL, Birnbaum HG, Morley MA, Asche C. Economic impact of antibiotic resistance in the treatment of community acquired pneumonia. Value in Health, 2000; 6(3): 259

Asche C. The economic costs of not treating. Proceedings of the "Investing in Our Future Older Persons and Substance Abuse" workshop. Etobicoke Coalition for the Prevention of Substance Misuse & Toronto Addiction Services Coalition, Toronto, 1999

Asche C, Coyte PC, Croxford R. Small area variations in physician practice patterns. International Health Economics Association (iHEA) 2nd World Congress, Rotterdam, 1999

Asche C. The cost of injuries. Proceedings of the Adult Injury Management Summit. Vancouver, 1998

Coyte PC, Asche CV, Ho E, Brassard T, Friedberg J. Paucity of reliable costing studies associated with otitis media management. Ann Otol Rhinol Laryngol. 1998 Jul; 107(7): 631

Coyte PC, Asche CV, Brassard T, Ho E, Friedberg J, 'Cost Analysis of Myringotomy with Insertion of Ventilation Tube in a National Health System' Annals of Otology, Rhinology & Laryngology, 1077, 631, 1998.

Asche CV, Hawker G, Chan B, Coyte PC, 'The Economic Cost and Social and Psychological Impact of Musculoskeletal Conditions Comment on the Article by Yelin et al' Arthritis & Rheumatism, 3911, 1931, 1997.

Asche C, Hosein I. Cost-effectiveness analysis of home-based palliative care. 6th International Conference on Systems Sciences in Health-Social Services for the Elderly and the Disabled, LF Heumann and S Miller (eds.) (University of Illinois at Urbana-Champaign Press), 356-360, 1997

Asche C, Gallagher EM, Coyte PC. The economic impact of falls among Canadian seniors. 6th International Conference on Systems Sciences in Health-Social Services for the Elderly and the Disabled, LF Heumann and S Miller (eds.) (University of Illinois at Urbana-Champaign Press), 428-432, 1997

Asche C, Gallagher EM, Coyte PC. The economic impact of falls among Canadian seniors. International Association of Gerontology (IAG) 16th World Congress on Gerontology, Adelaide, 1997

Asche C, Gallagher EM, Coyte PC. The economic impact of falls among Canadian seniors. 125th Annual Conference of the American Public Health Association (APHA), Indianapolis, 1997

Asche C. What is disease management? J Health Services Research and Policy. 1997 2(1): 62

Asche C. Economic dimensions of slip and fall injuries. J Forensic Sciences. 1997 42(4): 755

Asche C, Ho E, Coyte PC, Chan B. The economic costs of multiple sclerosis in Canada. Multiple Sclerosis. 1996. 2:98

Asche C, Ho E. "The economic consequences of multiple sclerosis among Canadians", 11th Annual Meeting of the Consortium of Multiple Sclerosis Centers, Atlanta, 1996

Asche C, Coyte PC, Chan B. The economic costs of musculoskeletal disorders among Canadian seniors. 25th Annual Scientific and Education Meeting of the Canadian Association of Gerontology (CAG), Quebec City, 1996

Asche C, Coyte PC, Chan B. The economic costs of musculoskeletal disorders among Canadian seniors. 124th Annual Conference of the American Public Health Association (APHA), New York City, 1996

Chapters

Coyte PC, Asche CV, Croxford R, Chan B, 'The Economic Cost of Arthritis and Rheumatism in Canada', in Patterns of Health Care in Ontario Arthritis and Related Conditions An ICES Practice Atlas, edited by EM Badley and JI Williams, (Institute for Clinical Evaluative Sciences Toronto), 1998.
 
Asche C,   "Chapter 3: The economic costs of injuries", in Adult Injury Management Preventing Unintentional Injuries Among Older Adults and Persons with Disabilities, edited by EM Gallagher and V Scott,  (University of Victoria, School of Nursing), 1997.

Go To...

• Profile
• Publications
• Courses Taught